Intuitive Surgical filings document operating results, governance matters, capital structure, and material events for a Nasdaq-listed medical technology company focused on robotic-assisted surgery. Its Form 8-K reports furnish quarterly and preliminary financial results, procedure information, and exhibits tied to da Vinci and Ion business performance.
Regulatory filings also cover shareholder voting matters, proxy governance, executive compensation, director elections, and officer-role changes. Other material-event disclosures record completed corporate actions, including the acquisition of da Vinci and Ion distribution operations in Europe, alongside formal disclosures about common stock and financial reporting matters.
INTUITIVE SURGICAL INC director Jami K. Nachtsheim reported routine equity compensation activity, with only share acquisitions and no sales. On April 30, 2026, she exercised 531 Restricted Stock Units into Common Stock, bringing her direct Common Stock holdings to 6,902 shares.
On the same date she also received a new grant of 554 Restricted Stock Units tied to Common Stock. According to the filing, 100% of these RSUs will vest on the earlier of one year from grant or the next Annual Meeting of Stockholders, as long as she continues in service.
INTUITIVE SURGICAL INC director Leonard Keith R reported equity compensation activity involving Restricted Stock Units (RSUs) and common stock. He exercised 531 RSUs into 531 shares of common stock on April 30, 2026, and did not report any same-day sales.
Following the exercise, he held 901 shares of common stock directly. On the same date, he also received a grant of 554 RSUs tied to common stock. According to the disclosure, 100% of these RSUs will vest on the earlier of the one-year anniversary of the grant date or the next Annual Meeting of Stockholders, subject to his continued service.
INTUITIVE SURGICAL INC director Amy L. Ladd reported compensation-related equity activity involving company stock. On April 30, 2026, she exercised 531 Restricted Stock Units, which converted into 531 shares of Common Stock, leaving her with 651 Common shares held directly after the transaction.
On the same date, she also received a new grant of 554 Restricted Stock Units, each representing a right to receive one share of Common Stock. According to the filing, 100% of these RSUs vest on the earlier of the one-year anniversary of the grant date or the next Annual Meeting of Stockholders, subject to her continued service.
Intuitive Surgical director Sreelakshmi Kolli reported equity compensation activity involving Restricted Stock Units (RSUs) and common stock. She exercised 531 RSUs into 531 shares of common stock and, after this transaction, directly held 1,510 shares of common stock.
She was also granted 554 new RSUs linked to common stock, which represent a new award of derivative securities. According to the disclosure, 100% of these RSUs will vest on the earlier of the one-year anniversary of the grant date or the next Annual Meeting of Stockholders, subject to her continued service.
Intuitive Surgical director Amal M. Johnson exercised 531 Restricted Stock Units into 531 shares of Common Stock. The RSUs vested based on service, with 100% vesting on the earlier of one year from grant or the next Annual Meeting of Stockholders. After this conversion, Johnson directly holds 13,545 shares of Common Stock, and the reported RSU award has been fully converted with no remaining balance shown.
INTUITIVE SURGICAL INC director Lewis Chew reported routine equity compensation changes. On April 30, 2026, he exercised 531 shares of restricted stock units into an equal number of common shares, bringing his direct common stock holdings to 1,314 shares after the transaction.
On the same date, he also received a new grant of 554 restricted stock units, each representing one share of common stock. According to the terms, 100% of these RSUs will vest on the earlier of one year from grant or the next Annual Meeting of Stockholders, assuming he continues in service.
INTUITIVE SURGICAL INC director Joseph C. Beery reported routine equity compensation activity. On April 30, 2026, he exercised 531 shares of Restricted Stock Units into Common Stock, bringing his direct Common Stock holdings to 3,641 shares after the transactions.
On the same date, he received a new grant of 554 Restricted Stock Units. According to the footnote, 100% of these RSUs will vest on the earlier of one year from the grant date or the next Annual Meeting of Stockholders, subject to his continued service. The filing shows only acquisitions and no open‑market buying or selling.
INTUITIVE SURGICAL INC director Craig H. Barratt reported equity compensation activity involving common stock and restricted stock units. On April 30, 2026, a trust associated with him acquired 750 shares of common stock through the exercise of restricted stock units, bringing its indirect holdings to 27,948 shares.
The same day, Barratt received a new grant of 643 restricted stock units, each representing one share of common stock. According to the disclosure, 100% of these RSUs vest on the earlier of the one-year anniversary of the grant date or the next Annual Meeting of Stockholders, subject to his continued service.
Vanguard Capital Management reported beneficial ownership of 26,601,419 shares of Intuitive Surgical common stock, representing 7.49% of the class as of 03/31/2026. The filing shows sole voting power over 3,521,929 shares and sole dispositive power over 26,601,419 shares. The report is signed by Ashley Grim on 04/30/2026.
INTUITIVE SURGICAL INC director Amy L. Ladd reported open-market sales of company Common Stock over two days. She sold 500 shares at $473.46 per share on April 28, 2026, and 119 shares at $463.50 per share on April 29, 2026. After these transactions, she directly holds 120 shares. The filing notes that the activity occurred under a Trading Plan that complies with SEC Rule 10b5-1 and runs through January 29, 2027, indicating the sales were pre-scheduled rather than discretionary.